BENZALKONIUM CHLORIDE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 319.0 | 6.6 | 0 | 0 | 0.0 | 14 | 0.73 |
- CAS
- 8001545
- UNII
- F5UM2KM3W7
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 10 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT00414739 | Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells | Phase 1 | Recruiting | |
| NCT02269800 | 2014-10-01 | An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD | Phase 4 | Not Yet Recruiting |
| NCT00845299 | 2009-01-01 | Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma | Phase 2 | Completed |
| NCT00692952 | 2004-03-01 | Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial | Phase 2 | Completed |
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Ophthalmic | Gel | 0.01% |
| Auricular (Otic) | Solution | 0.03% |
| Auricular (Otic) | Suspension | 0.02% |
| Inhalation | Solution | 20% |
| Inhalation | Spray | 0.0002% |
| Intra-Articular | Injectable | 0.02% |
| Intra-Articular | Injection | 0.01% |
| Intra-Articular | Suspension | 0.01% |
| Intrabursal | Injection | |
| Intradermal | Injection | |
| Intralesional | Injectable | 0.02% |
| Intralesional | Injection | |
| Intramuscular | Injectable | 0.02% |
| Intramuscular | Injection | 0.01% |
| Intramuscular | Suspension | 0.01% |
| Intraocular | Solution | 0.01% |
| Intrasynovial | Injection | 0.01% |
| Nasal | Gel | |
| Nasal | Solution | 1% |
| Nasal | Solution, Spray | 0.03% |
| Nasal | Spray | 0.12% |
| Nasal | Spray, Metered | 0.01%W/V |
| Ophthalmic | Drops | 0.0004% |
| Ophthalmic | Ointment | 0.03% |
| Ophthalmic | Solution | 40% |
| Ophthalmic | Solution, Drops | 0.9% |
| Ophthalmic | Solution/drops | 0.01% |
| Ophthalmic | Suspension | 0.03% |
| Ophthalmic | Suspension, Drops | 0.03% |
| Oral | Solution | 0.02% |
| Respiratory (Inhalation) | Solution, Spray | 0.0002% |
| Respiratory (Inhalation) | Spray | 0.01% |
| Topical | Jelly | |
| Topical | Lotion | 0.1% |
| Topical | Shampoo | 0.2% |
| Topical | Solution | 0.02%W/V |
| Topical | Solution, Drops | 0.02%W/V |
| Topical | Suspension | 0.01% |